Immunosenescence-related transcriptomic and immunologic changes in older individuals following influenza vaccination

Frontiers in Immunology

Volumn 7, Issue NOV, 2016, Pages

  Kennedy, Richard B ^a   Ovsyannikova, Inna G ^a   Haralambieva, Iana H ^a   Oberg, Ann L ^a   Zimmermann, Michael T ^a   Grill, Diane E ^a   Poland, Gregory A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Aging; DNA methylation; Gene expression profiling; Immunity; Influenza A H1N1 virus; Influenza vaccines; MiRNA

Indexed keywords

BREAKPOINT CLUSTER REGION PROTEIN; CD28 ANTIGEN; CD4 ANTIGEN; CD86 ANTIGEN; HLA ANTIGEN; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; MICRORNA 125B 5P; MICRORNA 196A 5P; MICRORNA 335 5P; MICRORNA 7 5P; MICRORNA 9 5P; MITOGEN ACTIVATED PROTEIN KINASE; T LYMPHOCYTE RECEPTOR; TELOMERASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; DNA METHYLATION; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HEMAGGLUTINATION TEST; HUMAN; IMMUNE RESPONSE; IMMUNOPHENOTYPING; IMMUNOSENESCENCE; INFLUENZA VACCINATION; LIQUID CHROMATOGRAPHY; NEXT GENERATION SEQUENCING; NORMAL HUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS; VIRUS NEUTRALIZATION;

EID: 85006108550     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00450     Document Type: Article

References (96)

1. Franceschi C, Bonafe M, Valensin S. Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine (2000) 18(16):1717-20. doi:10.1016/S0264-410X(99)00513-7
2. Haq K, McElhaney JE. Immunosenescence: influenza vaccination and the elderly. Curr Opin Immunol (2014) 29:38-42. doi:10.1016/j.coi.2014.03.008
3. Linton PJ, Thoman ML. Immunosenescence in monocytes, macrophages, and dendritic cells: lessons learned from the lung and heart. Immunol Lett (2014) 162(1 Pt B):290-7. doi:10.1016/j.imlet.2014.06.017
4. Pritz T, Weinberger B, Grubeck-Loebenstein B. The aging bone marrow and its impact on immune responses in old age. Immunol Lett (2014) 162(1 Pt B):310-5. doi:10.1016/j.imlet.2014.06.016
5. Fulop T, McElhaney J, Pawelec G, Cohen AA, Morais JA, Dupuis G, et al. Frailty, inflammation and immunosenescence. Interdiscip Top Gerontol Geriatr (2015) 41:26-40. doi:10.1159/000381134
6. Shrestha SS, Swerdlow DL, Borse RH, Prabhu VS, Finelli L, Atkins CY, et al. Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). Clin Infect Dis (2011) 52(Suppl 1):S75-82. doi:10.1093/cid/ciq012
7. Nguyen AM, Noymer A. Influenza mortality in the United States, 2009 pandemic: burden, timing and age distribution. PLoS One (2013) 8(5):e64198. doi:10.1371/journal.pone.0064198
8. Beyer WE, McElhaney J, Smith DJ, Monto AS, Nguyen-Van-Tam JS, Osterhaus AD. Cochrane re-arranged: support for policies to vaccinate elderly people against influenza. Vaccine (2013) 31(50):6030-3. doi:10.1016/j.vaccine.2013.09.063
9. Ortman JM, Velkoff VA, Hogan H. US Census Bureau. An Aging Nation: The Older Population in the United States. Current Population Reports. Washington, DC (2014). Report Number P25-1140.
10. Foged C. Thermostable subunit vaccines for pulmonary delivery: how close are we? Curr Pharm Des (2016) 22(17):2561-76. doi:10.2174/1381612822666160202141603
11. Kim YC, Lee SH, Choi WH, Choi HJ, Goo TW, Lee JH, et al. Microneedle delivery of trivalent influenza vaccine to the skin induces long-term cross-protection. J Drug Target (2016):1-9. doi:10.3109/1061186X.2016.1159213
12. Yam KK, Gupta J, Allen EK, Burt KR, Beaulieu E, Mallett CP, et al. Comparison of AS03 and Alum on immune responses elicited by A/H3N2 split influenza vaccine in young, mature and aged BALB/c mice. Vaccine (2016) 34(12):1444-51. doi:10.1016/j.vaccine.2016.02.012
13. Zurli V, Gallotta M, Taccone M, Chiarot E, Brazzoli M, Corrente F, et al. Positive contribution of adjuvanted influenza vaccines to the resolution of bacterial superinfections. J Infect Dis (2016) 213(12):1876-85. doi:10.1093/infdis/jiw048
14. Haralambieva IH, Painter SD, Kennedy RB, Ovsyannikova IG, Lambert ND, Goergen KM, et al. The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects. PLoS One (2015) 10(3):e0122282. doi:10.1371/journal.pone.0122282
15. Salk HM, Haralambieva IH, Ovsyannikova IG, Goergen KM, Poland GA. Granzyme B ELISPOT assay to measure influenza-specific cellular immunity. J Immunol Methods (2013) 398-399:44-50. doi:10.1016/j.jim.2013.09.007
16. Targonski PV, Caldwell CR, Strausbauch M, Wettstein P, Poland GA, Tangalos EG. White blood cell telomerase activity and incident respiratory illness among community-dwelling elderly vaccinated against seasonal influenza. Clin Pharmacol Ther (2007) 82(6):694-9. doi:10.1038/sj.clpt.6100410
17. Rizza P, Capone I, Urbani F, Montefiore E, Rapicetta M, Chionne P, et al. Evaluation of the effects of human leukocyte IFN-alpha on the immune response to the HBV vaccine in healthy unvaccinated individuals. Vaccine (2008) 26(8):1038-49. doi:10.1016/j.vaccine.2007.12.044
18. Webster R, Cox N, Stohr K. WHO Manual on Animal Influenza Diagnosis and Surveillance. Geneva: World Health Organization (2002).
19. Painter SD, Haralambieva IH, Ovsyannikova IG, Grill DE, Poland GA. Detection of influenza A/H1N1-specific human IgG-secreting B cells in older adults by ELISPOT assay. Viral Immunol (2014) 27(2):32-8. doi:10.1089/vim.2013.0099
20. Kennedy RB, Oberg AL, Ovsyannikova IG, Haralambieva IH, Grill D, Poland GA. Transcriptomic profiles of high and low antibody responders to smallpox vaccine. Genes Immun (2013) 14(5):277-85. doi:10.1038/gene.2013.14
21. Zhong Y, Wan YW, Pang K, Chow LM, Liu Z. Digital sorting of complex tissues for cell type-specific gene expression profiles. BMC Bioinformatics (2013) 14:89. doi:10.1186/1471-2105-14-89
22. Ovsyannikova IG, White SJ, Albrecht RA, Garcia-Sastre A, Poland GA. Turkey versus guinea pig red blood cells: hemagglutination differences alter hemagglutination inhibition responses against influenza A/H1N1. Viral Immunol (2014) 27(4):174-8. doi:10.1089/vim.2013.0111
23. Haralambieva IH, Ovsyannikova IG, Kennedy RB, Zimmermann MT, Grill DE, Oberg AL, et al. Transcriptional signatures of influenza A/H1N1-specific IgG memory-like B cell response in older individuals. Vaccine (2016) 34(34):3993-4002. doi:10.1016/j.vaccine.2016.06.034
24. Ovsyannikova IG, Oberg AL, Kennedy RB, Zimmermann MT, Haralambieva IH, Goergen KM, et al. Gene signatures related to HAI response following influenza A/H1N1 vaccine in older individuals. Heliyon (2016) 2:e00098. doi:10.1016/j.heliyon.2016.e00098
25. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol (2009) 10(3):R25. doi:10.1186/gb-2009-10-3-r25
26. Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics (2009) 25(9):1105-11. doi:10.1093/bioinformatics/btp120
27. Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics (2010) 26(6):841-2. doi:10.1093/bioinformatics/btq033
28. Anders S, Pyl PT, Huber W. HTSeq: analysing high-throughput sequencing data with Python. Bioinformatics (2015) 31(2):166-9. doi:10.1093/bioinformatics/btu638
29. Zimmermann MT, Oberg AL, Grill DE, Ovsyannikova IG, Haralambieva IH, Kennedy RB, et al. System-wide associations between DNA-methylation, gene expression, and humoral immune response to influenza vaccination. PLoS One (2016) 11(3):e0152034. doi:10.1371/journal.pone.0152034
30. Marabita F, Almgren M, Lindholm ME, Ruhrmann S, Fagerstrom-Billai F, Jagodic M, et al. An evaluation of analysis pipelines for DNA methylation profiling using the Illumina HumanMethylation450 BeadChip platform. Epigenetics (2013) 8(3):333-46. doi:10.4161/epi.24008
31. Teschendorff AE, Marabita F, Lechner M, Bartlett T, Tegner J, Gomez-Cabrero D, et al. A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics (2013) 29(2):189-96. doi:10.1093/bioinformatics/bts680
32. Oberg AL, McKinney BA, Schaid DJ, Pankratz VS, Kennedy RB, Poland GA. Lessons learned in the analysis of high-dimensional data in vaccinomics. Vaccine (2015) 33(40):5262-70. doi:10.1016/j.vaccine.2015.04.088
33. Oberg AL, Mahoney DW, Eckel-Passow JE, Malone CJ, Wolfinger RD, Hill EG, et al. Statistical analysis of relative labeled mass spectrometry data from complex samples using ANOVA. J Proteome Res (2008) 7(1):225-33. doi:10.1021/pr700734f
34. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A (2003) 100(16):9440-5. doi:10.1073/pnas.1530509100
35. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B (1995) 57:289-300.
36. Chaussabel D, Quinn C, Shen J, Patel P, Glaser C, Baldwin N, et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity (2008) 29(1):150-64. doi:10.1016/j.immuni.2008.05.012
37. Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw (2010) 33(1):1-22. doi:10.18637/jss.v033.i01
38. Heiskanen M. Pathway Interaction Database. (2016). Available from: http://pid.nci.nih.gov/about.shtml#cite
39. Prasad TS, Kandasamy K, Pandey A. Human protein reference database and human proteinpedia as discovery tools for systems biology. Methods Mol Biol (2009) 577:67-79. doi:10.1007/978-1-60761-232-2_6
40. Rolland T, Tasan M, Charloteaux B, Pevzner SJ, Zhong Q, Sahni N, et al. A proteome-scale map of the human interactome network. Cell (2014) 159(5):1212-26. doi:10.1016/j.cell.2014.10.050
41. Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res (2011) 39(Database issue):D561-8. doi:10.1093/nar/gkq973
42. Lee I, Blom UM, Wang PI, Shim JE, Marcotte EM. Prioritizing candidate disease genes by network-based boosting of genome-wide association data. Genome Res (2011) 21(7):1109-21. doi:10.1101/gr.118992.110
43. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res (2003) 13(11):2498-504. doi:10.1101/gr.1239303
44. Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res (2000) 28(1):27-30. doi:10.1093/nar/28.1.27
45. Kanehisa M, Goto S, Sato Y, Kawashima M, Furumichi M, Tanabe M. Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res (2014) 42(Database issue):D199-205. doi:10.1093/nar/gkt1076
46. Chaussabel D, Baldwin N. Democratizing systems immunology with modular transcriptional repertoire analyses. Nat Rev Immunol (2014) 14(4):271-80. doi:10.1038/nri3642
47. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol (2003) 4(5):3. doi:10.1186/gb-2003-4-9-r60
48. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 4(1):44-57. doi:10.1038/nprot.2008.211
49. Wikby A, Maxson P, Olsson J, Johansson B, Ferguson FG. Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study. Mech Ageing Dev (1998) 102(2-3):187-98. doi:10.1016/S0047-6374(97)00151-6
50. Savva GM, Pachnio A, Kaul B, Morgan K, Huppert FA, Brayne C, et al. Cytomegalovirus infection is associated with increased mortality in the older population. Aging Cell (2013) 12(3):381-7. doi:10.1111/acel.12059
51. Reynolds LM, Taylor JR, Ding J, Lohman K, Johnson C, Siscovick D, et al. Age-related variations in the methylome associated with gene expression in human monocytes and T cells. Nat Commun (2014) 5:5366. doi:10.1038/ncomms6366
52. Aalaei-Andabili SH, Rezaei N. MicroRNAs (MiRs) precisely regulate immune system development and function in immunosenescence process. Int Rev Immunol (2015) 35(1):57-66. doi:10.3109/08830185.2015.1077828
53. Wikby A, Mansson IA, Johansson B, Strindhall J, Nilsson SE. The immune risk profile is associated with age and gender: findings from three Swedish population studies of individuals 20-100 years of age. Biogerontology (2008) 9(5):299-308. doi:10.1007/s10522-008-9138-6
54. Strindhall J, Skog M, Ernerudh J, Bengner M, Lofgren S, Matussek A, et al. The inverted CD4/CD8 ratio and associated parameters in 66-year-old individuals: the Swedish HEXA immune study. Age (2013) 35(3):985-91. doi:10.1007/s11357-012-9400-3
55. Bell JT, Tsai PC, Yang TP, Pidsley R, Nisbet J, Glass D, et al. Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population. PLoS Genet (2012) 8(4):e1002629. doi:10.1371/journal.pgen.1002629
56. Heyn H, Li N, Ferreira HJ, Moran S, Pisano DG, Gomez A, et al. Distinct DNA methylomes of newborns and centenarians. Proc Natl Acad Sci U S A (2012) 109(26):10522-7. doi:10.1073/pnas.1120658109
57. Florath I, Butterbach K, Muller H, Bewerunge-Hudler M, Brenner H. Cross-sectional and longitudinal changes in DNA methylation with age: an epigenome-wide analysis revealing over 60 novel age-associated CpG sites. Hum Mol Genet (2013) 23(5):1186-201. doi:10.1093/hmg/ddt531
58. Hannum G, Guinney J, Zhao L, Zhang L, Hughes G, Sadda S, et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell (2013) 49(2):359-67. doi:10.1016/j.molcel.2012.10.016
59. Steegenga WT, Boekschoten MV, Lute C, Hooiveld GJ, de Groot PJ, Morris TJ, et al. Genome-wide age-related changes in DNA methylation and gene expression in human PBMCs. Age (2014) 36(3):9648. doi:10.1007/s11357-014-9648-x
60. Xu Z, Taylor JA. Genome-wide age-related DNA methylation changes in blood and other tissues relate to histone modification, expression and cancer. Carcinogenesis (2014) 35(2):356-64. doi:10.1093/carcin/bgt391
61. Weidner CI, Lin Q, Koch CM, Eisele L, Beier F, Ziegler P, et al. Aging of blood can be tracked by DNA methylation changes at just three CpG sites. Genome Biol (2014) 15(2):R24. doi:10.1186/gb-2014-15-2-r24
62. Nakamura S, Kawai K, Takeshita Y, Honda M, Takamura T, Kaneko S, et al. Identification of blood biomarkers of aging by transcript profiling of whole blood. Biochem Biophys Res Commun (2012) 418(2):313-8. doi:10.1016/j.bbrc.2012.01.018
63. Vo TK, Godard P, de Saint-Hubert M, Morrhaye G, Bauwens E, Debacq-Chainiaux F, et al. Transcriptomic biomarkers of human ageing in peripheral blood mononuclear cell total RNA. Exp Gerontol (2010) 45(3):188-94. doi:10.1016/j.exger.2009.12.001
64. Mazzatti DJ, White A, Forsey RJ, Powell JR, Pawelec G. Gene expression changes in long-term culture of T-cell clones: genomic effects of chronic antigenic stress in aging and immunosenescence. Aging Cell (2007) 6(2):155-63. doi:10.1111/j.1474-9726.2007.00269.x
65. Gombar S, Jung HJ, Dong F, Calder B, Atzmon G, Barzilai N, et al. Comprehensive microRNA profiling in B-cells of human centenarians by massively parallel sequencing. BMC Genomics (2012) 13:353. doi:10.1186/1471-2164-13-353
66. ElSharawy A, Keller A, Flachsbart F, Wendschlag A, Jacobs G, Kefer N, et al. Genome-wide miRNA signatures of human longevity. Aging Cell (2012) 11(4):607-16. doi:10.1111/j.1474-9726.2012.00824.x
67. Feng R, Sang Q, Zhu Y, Fu W, Liu M, Xu Y, et al. MiRNA-320 in the human follicular fluid is associated with embryo quality in vivo and affects mouse embryonic development in vitro. Sci Rep (2015) 5:8689. doi:10.1038/srep08689
68. Ling HY, Ou HS, Feng SD, Zhang XY, Tuo QH, Chen LX, et al. CHANGES IN microRNA (miR) profile and effects of miR-320 in insulin-resistant 3T3-L1 adipocytes. Clin Exp Pharmacol Physiol (2009) 36(9):e32-9. doi:10.1111/j.1440-1681.2009.05207.x
69. Hsieh IS, Chang KC, Tsai YT, Ke JY, Lu PJ, Lee KH, et al. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway. Carcinogenesis (2013) 34(3):530-8. doi:10.1093/carcin/bgs371
70. Effros RB, Boucher N, Porter V, Zhu X, Spaulding C, Walford RL, et al. Decline in CD28+ T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence. Exp Gerontol (1994) 29(6):601-9. doi:10.1016/0531-5565(94)90073-6
71. Pawelec G, Wagner W, Adibzadeh M, Engel A. T cell immunosenescence in vitro and in vivo. Exp Gerontol (1999) 34(3):419-29. doi:10.1016/S0531-5565(99)00002-9
72. Boucher N, Dufeu-Duchesne T, Vicaut E, Farge D, Effros RB, Schachter F. CD28 expression in T cell aging and human longevity. Exp Gerontol (1998) 33(3):267-82. doi:10.1016/S0531-5565(97)00132-0
73. Wikby A, Johansson B, Ferguson F, Olsson J. Age-related changes in immune parameters in a very old population of Swedish people: a longitudinal study. Exp Gerontol (1994) 29(5):531-41. doi:10.1016/0531-5565(94)90036-1
74. Hadrup SR, Strindhall J, Kollgaard T, Seremet T, Johansson B, Pawelec G, et al. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J Immunol (2006) 176(4):2645-53. doi:10.4049/jimmunol.176.4.2645
75. Amadori A, Zamarchi R, De Silvestro G, Forza G, Cavatton G, Danieli GA, et al. Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med (1995) 1(12):1279-83. doi:10.1038/nm1295-1279
76. Vogel C, Marcotte EM. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet (2012) 13(4):227-32. doi:10.1038/nrg3185
77. Patil A, Kumagai Y, Liang KC, Suzuki Y, Nakai K. Linking transcriptional changes over time in stimulated dendritic cells to identify gene networks activated during the innate immune response. PLoS Comput Biol (2013) 9(11):e1003323. doi:10.1371/journal.pcbi.1003323
78. McElhaney JE, Xie D, Hager WD, Barry MB, Wang Y, Kleppinger A, et al. T cell responses are better correlates of vaccine protection in the elderly. J Immunol (2006) 176(10):6333-9. doi:10.4049/jimmunol.176.10.6333
79. Panda A, Arjona A, Sapey E, Bai F, Fikrig E, Montgomery RR, et al. Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol (2009) 30(7):325-33. doi:10.1016/j.it.2009.05.004
80. Solana R, Tarazona R, Gayoso I, Lesur O, Dupuis G, Fulop T. Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans. Semin Immunol (2012) 24(5):331-41. doi:10.1016/j.smim.2012.04.008
81. Haralambieva IH, Poland GA. Vaccinomics, predictive vaccinology and the future of vaccine development. Future Microbiol (2010) 5(12):1757-60. doi:10.2217/fmb.10.146
82. Bernstein A, Pulendran B, Rappuoli R. Systems vaccinomics: the road ahead for vaccinology. OMICS (2011) 15(9):529-31. doi:10.1089/omi.2011.0022
83. Ovsyannikova IG, Poland GA. Vaccinomics: current findings, challenges and novel approaches for vaccine development. AAPS J (2011) 13(3):438-44. doi:10.1208/s12248-011-9281-x
84. Poland GA, Ovsyannikova IG, Kennedy RB, Haralambieva IH, Jacobson RM. Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections. OMICS (2011) 15(9):625-36. doi:10.1089/omi.2011.0032
85. Lambert ND, Ovsyannikova IG, Pankratz VS, Jacobson RM, Poland GA. Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approach. Expert Rev Vaccines (2012) 11(8):985-94. doi:10.1586/erv.12.61
86. Poland GA, Ovsyannikova IG, Jacobson RM. Vaccinomics and personalized vaccinology. The Jordan Report. Washington, DC: U.S. Department of Health and Human Services (2012).
87. Poland GA, Kennedy RB, McKinney BA, Ovsyannikova IG, Lambert ND, Jacobson RM, et al. Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century. Semin Immunol (2013) 25(2):89-103. doi:10.1016/j.smim.2013.04.007
88. O'Connor JE, Herrera G, Martinez-Romero A, de Oyanguren FS, Diaz L, Gomes A, et al. Systems biology and immune aging. Immunol Lett (2014) 162(1 Pt B):334-45. doi:10.1016/j.imlet.2014.09.009
89. Minutello M, Senatore F, Cecchinelli G, Bianchi M, Andreani T, Podda A, et al. Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons. Vaccine (1999) 17(2):99-104. doi:10.1016/S0264-410X(98)00185-6
90. Frey SE, Reyes MR, Reynales H, Bermal NN, Nicolay U, Narasimhan V, et al. Comparison of the safety and immunogenicity of an MF59(R)-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects. Vaccine (2014) 32(39):5027-34. doi:10.1016/j.vaccine.2014.07.013
91. Seo YB, Choi WS, Lee J, Song JY, Cheong HJ, Kim WJ. Comparison of the immunogenicity and safety of the conventional subunit, MF59-adjuvanted, and intradermal influenza vaccines in the elderly. Clin Vaccine Immunol (2014) 21(7):989-96. doi:10.1128/CVI.00615-13
92. Behzad H, Huckriede AL, Haynes L, Gentleman B, Coyle K, Wilschut JC, et al. GLA-SE, a synthetic toll-like receptor 4 agonist, enhances T-cell responses to influenza vaccine in older adults. J Infect Dis (2012) 205(3):466-73. doi:10.1093/infdis/jir769
93. Jiang J, Fisher EM, Concannon M, Lustigman S, Shen H, Murasko DM. Enhanced humoral response to influenza vaccine in aged mice with a novel adjuvant, rOv-ASP-1. Vaccine (2016) 34(7):887-92. doi:10.1016/j.vaccine.2016.01.003
94. Gschoesser C, Almanzar G, Hainz U, Ortin J, Schonitzer D, Schild H, et al. CD4+ and CD8+ mediated cellular immune response to recombinant influenza nucleoprotein. Vaccine (2002) 20(31-32):3731-8. doi:10.1016/S0264-410X(02)00355-9
95. Doucet JD, Forget MA, Grange C, Rouxel RN, Arbour N, von Messling V, et al. Endogenously expressed matrix protein M1 and nucleoprotein of influenza A are efficiently presented by class I and class II major histocompatibility complexes. J Gen Virol (2011) 92(Pt 5):1162-71. doi:10.1099/vir.0.029777-0
96. Lefebvre JS, Haynes L. Vaccine strategies to enhance immune responses in the aged. Curr Opin Immunol (2013) 25(4):523-8. doi:10.1016/j.coi.2013.05.014